EGF+61 A>G polymorphism does not predict response to first‐generation EGFR tyrosine kinase inhibitors in lung cancer patients
Leal, Leticia F., Laus, Ana C., Cavagna, Rodrigo, Paula, Flavia E., Oliveira, Marco A., Ribeiro, Dayana M., Hassan, Fernanda M., Miziara, José E., Silva, Eduardo C. Albino, Silva, Vinicius D., De Marchi, Pedro, Reis, Rui M.
Published in Thoracic cancer (01.10.2020)
Published in Thoracic cancer (01.10.2020)
Get full text
Journal Article